Researcher Recognized for Work on Promising Synthetic CBD-derived Drug
EHP-101 has shown promise for the modulation of relevant multiple sclerosis targets, having PPARγ and CB2-mediated anti-inflammatory activity, and the potential to enhance remyelination.
Proposal Seeks to Improve Assessment of Drug Risks
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
Canadian University to Examine Efficacy of CBD for Pain, Anxiety and Depression
The project will investigate the pain relief properties of CBD oil by exploring its mechanism of action in pain and associated depression and anxiety.
Aurora Cannabis Completes Acquisition of Anandia Laboratories
Anandia is the Canadian leader in independent third-party testing and was awarded "Top Testing Lab" at the 2017 Lift Canadian Cannabis Awards.
Association of Cannabis Specialists Publishes 8 Steps to U.S. Federal Cannabis Legalization
With only a patchwork of state cannabis laws currently in existence, these new recommendations offer a unified federal framework to help optimize the care of patients across the country.
California Cannabis Testing Highlights the Importance of Quality Control
According to statistics provided by California’s Bureau of Cannabis Control, 20% of all cannabis products analyzed by August 6, 2018, received a failed certificate of analysis.
Misleading Press Coverage Could Impact Use of Medicinal Cannabis
The media is claiming that long-term cannabis use could result in damage to the human brain based on findings from a research study that used neither cannabis or humans.
How Cannabis Relieves Intestinal Inflammation Has Been Revealed
This is the first time scientists have reported a biological mechanism to explain why some marijuana users have reported beneficial effects from cannabis on intestine inflammation conditions such as ulcerative colitis and Crohn's disease.
Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes
The extraction processes provide highly-efficient methods to obtain cannabinoids and other desired compounds from the cannabis plant at a greater purity than conventional methods.
Specific Therapeutic Benefits of Cannabidiol Validated by FDA
What's most transformative about this drug approval is that this is the first time the FDA - the governmental arbiter of safe and effective medicine in the United States - has approved any substance derived from the cannabis plant.
